Jennifer J. Rhodes, See Remarks at Angion Biomedica Corp. (ANGN), sold 430 shares at $8.65 ($4K) on 2021-10-14, disclosed to the SEC on 2021-10-15.
Scheduled sale ($4k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ANGN | SELL | 2021-12-15 | $1K | — | Filing → |
| ANGN | SELL | 2021-11-16 | $2K | — | Filing → |
| ANGN | SELL | 2021-09-15 | $5K | — | Filing → |